Efgartigimod alfa
Product Specifications
CAS Number
1821402-21-4
Bioactivity
Efgartigimod alfa is an Fc receptor blocker used to treat myasthenia gravis. It reduces overall IgG levels, including the pathogenic acetylcholine receptor (AChR) antibodies found in myasthenia gravis. Additionally, it can be formulated with hyaluronidase.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IFIH1-2022R 50 µg
Recombinant Rhesus Macaque IFIH1 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details